News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–43
Matches
43
Sources here
5
Companies here
1
Search results Stored financial headlines

Active search

43 matching headlines

Ticker or company: TMCIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Intellectia AI Earnings Main company 🇺🇸 United States

Treace Medical Concepts to Release Q2 2026 Financial Results

Treace Medical Concepts (TMCI) is scheduled to release its Q2 2026 financial results before trading on August 7, 2026, followed by a conference call at 8:00 am ET. The company is highlighting its significant market potential, targeting 1.1 million surgical candidates among 67 million …

TMCI main company
Sharemaestro market context Trend signal active 52 weeks -37.8% TMCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Treace will discuss Q2 results live before markets open Aug. 7

Treace Medical Concepts (NasdaqGS: TMCI) will announce its second-quarter 2026 financial results before market open on Friday, August 7, 2026. The company will host a conference call at 8:00 a.m. ET, which will also be accessible via a live webcast on its investor relations …

TMCI main company
Sharemaestro market context Trend signal active 52 weeks -37.8% TMCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
The Manila Times Earnings Main company 🇺🇸 United States

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

Treace Medical Concepts, Inc. (NasdaqGS: TMCI) announced it will release its second quarter 2026 financial results before market open on Friday, August 7, 2026. The company will host a conference call at 8:00 am ET to discuss these results. Interested investors can register for …

TMCI main company
Sharemaestro market context Trend signal active 52 weeks -37.8% TMCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from Brokerages

Treace Medical Concepts (NASDAQ: TMCI) has received a "Reduce" consensus rating from seven brokerages, with an average 12-month price target of $4.97. Despite analysts' cautious outlook, the company exceeded recent quarterly earnings and revenue estimates. Notably, insider and institutional buying has been strong, with …

TMCI main company
Sharemaestro market context Trend signal active 52 weeks -37.8% TMCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Moomoo Analyst action Main company 🇺🇸 United States

Treace Medical Concepts Price Target Raised to $4.00/Share From $2.00 by Truist Securities

Truist Securities has raised its price target for Treace Medical Concepts (NASDAQ: TMCI) shares to $4.00, up from the previous target of $2.00. This adjustment follows the firm's re-evaluation of the medical device company's financial outlook. While the price target has increased, Truist Securities …

TMCI main company
Sharemaestro market context Trend signal active 52 weeks -37.8% TMCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

Treace Medical Concepts (NASDAQ:TMCI) Given New $4.00 Price Target at Truist Financial

Truist Financial has increased its price target for Treace Medical Concepts (NASDAQ:TMCI) to $4.00, up from $2.00, while maintaining a "hold" rating, suggesting an 11.6% potential downside. The company recently reported better-than-expected quarterly results with an EPS of -$0.28 and revenue of $47.2 million, …

TMCI main company
Sharemaestro market context Trend signal active 52 weeks -37.8% TMCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest Down 46.6% in June

Treace Medical Concepts, Inc. (NASDAQ:TMCI) experienced a significant 46.6% decline in short interest in June, bringing the total to 1.75 million shares or about 3.5% of its outstanding shares. Despite weak fundamentals, including a negative net margin and anticipated full-year loss, insider buying has …

TMCI main company
Sharemaestro market context Trend signal active 52 weeks -37.8% TMCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context